
Synchneuro, Inc.
Revolutionizing health monitoring through brain signals
San Francisco, United States · Founded 2021 · $3.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2C
- Website
- synchneuro.com
- Total Funding
- $3.0M
- Last Round
- $3.0M SeedNov 2025
- Rounds
- 1
About
SynchNeuro is developing the world's first non-invasive, brain-based continuous glucose monitor. Its discreet behind-the-ear EEG sensor analyzes brain signals to track glucose levels, sleep quality, and other metabolic metrics without needles or skin puncture. Machine learning models translate brainwave patterns into real-time metabolic health insights.
Summary
Synchneuro, Inc. is a Medtech company based in San Francisco, United States, founded in 2021. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Nov 2025. Investors include Boomerang Ventures and Plug and Play.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.

xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...